To pursue a less invasive translational approach, we investigated whether intranasal administration of NPY would alleviate cerebellar neuropathology and motor and balance impairments in a severe MJD transgenic mouse model. The gene discussed is NPY; the disease is Spinocerebellar ataxia type 3.